Axogen, Inc. — Director's Dealing 2021

Dec 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2021-12-15

Reporting Person: DeVinney Erick Wayne (VP Peripheral Nerve Science)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-15	Common Stock	M	10000	$3.67	Acquired	90426	Direct
2021-12-15	Common Stock	F	4171	$8.80	Disposed	86255	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-15	Employee Stock Option (right to buy)	$3.67	M	10000	Disposed	2021-12-29	Common Stock (10000.0)	Direct

Footnotes

F1: This reflects the number of shares that became vested as of December 29, 2018.

F2: Represents the number of shares swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule16b-3.